ID	Gene Name	Species	BBID	BIOCARTA	GOTERM_BP_DIRECT	GOTERM_CC_DIRECT	GOTERM_MF_DIRECT	INTERPRO	KEGG_PATHWAY	OMIM_DISEASE	SMART	UP_KEYWORDS	UP_SEQ_FEATURE
5925	RB transcriptional corepressor 1(RB1)	Homo sapiens	94.E2F_transcriptional_activity_cell_cycle,	h_arfPathway:Tumor Suppressor Arf Inhibits Ribosomal Biogenesis,h_btg2Pathway:BTG family proteins and cell cycle regulation,h_cellcyclePathway:Cyclins and Cell Cycle Regulation,h_fasPathway:FAS signaling pathway ( CD95 ),h_fbw7Pathway:Cyclin E Destruction Pathway,h_g1Pathway:Cell Cycle: G1/S Check Point ,h_hcmvPathway:Human Cytomegalovirus and Map Kinase Pathways,h_hivnefPathway:HIV-I Nef: negative effector of Fas and TNF,h_p27Pathway:Regulation of p27 Phosphorylation during Cell Cycle Progression,h_p53Pathway:p53 Signaling Pathway,h_pmlPathway:Regulation of transcriptional activity by PML,h_PparaPathway:Mechanism of Gene Regulation by Peroxisome Proliferators via PPARa(alpha),h_raccycdPathway:Influence of Ras and Rho proteins on G1 to S Transition,h_rbPathway:RB Tumor Suppressor/Checkpoint Signaling in response to DNA damage,h_skp2e2fPathway:E2F1 Destruction Pathway,h_telPathway:Telomeres, Telomerase, Cellular Aging, and  Immortality,h_tercPathway:Overview of telomerase RNA component gene hTerc Transcriptional Regulation,h_tidPathway:Chaperones modulate interferon Signaling Pathway,h_tnfr1Pathway:TNFR1 Signaling Pathway,	GO:0000075~cell cycle checkpoint,GO:0000082~G1/S transition of mitotic cell cycle,GO:0000083~regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0000122~negative regulation of transcription from RNA polymerase II promoter,GO:0001558~regulation of cell growth,GO:0001894~tissue homeostasis,GO:0006338~chromatin remodeling,GO:0006351~transcription, DNA-templated,GO:0006357~regulation of transcription from RNA polymerase II promoter,GO:0006469~negative regulation of protein kinase activity,GO:0006915~apoptotic process,GO:0007050~cell cycle arrest,GO:0007070~negative regulation of transcription from RNA polymerase II promoter during mitosis,GO:0007093~mitotic cell cycle checkpoint,GO:0007265~Ras protein signal transduction,GO:0007346~regulation of mitotic cell cycle,GO:0008285~negative regulation of cell proliferation,GO:0010629~negative regulation of gene expression,GO:0016032~viral process,GO:0016569~covalent chromatin modification,GO:0030521~androgen receptor signaling pathway,GO:0031134~sister chromatid biorientation,GO:0031175~neuron projection development,GO:0034088~maintenance of mitotic sister chromatid cohesion,GO:0034349~glial cell apoptotic process,GO:0035914~skeletal muscle cell differentiation,GO:0042551~neuron maturation,GO:0043353~enucleate erythrocyte differentiation,GO:0043433~negative regulation of sequence-specific DNA binding transcription factor activity,GO:0043550~regulation of lipid kinase activity,GO:0045445~myoblast differentiation,GO:0045651~positive regulation of macrophage differentiation,GO:0045842~positive regulation of mitotic metaphase/anaphase transition,GO:0045879~negative regulation of smoothened signaling pathway,GO:0045892~negative regulation of transcription, DNA-templated,GO:0045893~positive regulation of transcription, DNA-templated,GO:0045944~positive regulation of transcription from RNA polymerase II promoter,GO:0048565~digestive tract development,GO:0048667~cell morphogenesis involved in neuron differentiation,GO:0050680~negative regulation of epithelial cell proliferation,GO:0051146~striated muscle cell differentiation,GO:0051301~cell division,GO:0051402~neuron apoptotic process,GO:0051726~regulation of cell cycle,GO:0071459~protein localization to chromosome, centromeric region,GO:0071466~cellular response to xenobiotic stimulus,GO:0071922~regulation of cohesin loading,GO:0071930~negative regulation of transcription involved in G1/S transition of mitotic cell cycle,GO:0090230~regulation of centromere complex assembly,GO:0097284~hepatocyte apoptotic process,GO:2000134~negative regulation of G1/S transition of mitotic cell cycle,GO:2000679~positive regulation of transcription regulatory region DNA binding,	GO:0000785~chromatin,GO:0005634~nucleus,GO:0005654~nucleoplasm,GO:0005819~spindle,GO:0008024~cyclin/CDK positive transcription elongation factor complex,GO:0016514~SWI/SNF complex,GO:0016605~PML body,GO:0035189~Rb-E2F complex,	GO:0001047~core promoter binding,GO:0001102~RNA polymerase II activating transcription factor binding,GO:0003677~DNA binding,GO:0003700~transcription factor activity, sequence-specific DNA binding,GO:0003713~transcription coactivator activity,GO:0005515~protein binding,GO:0008134~transcription factor binding,GO:0019900~kinase binding,GO:0031625~ubiquitin protein ligase binding,GO:0042802~identical protein binding,GO:0050681~androgen receptor binding,GO:0051219~phosphoprotein binding,	IPR002719:Retinoblastoma-associated protein, B-box,IPR002720:Retinoblastoma-associated protein, A-box,IPR013763:Cyclin-like,IPR015030:Rb C-terminal,IPR024599:Domain of unknown function DUF3452, retinoblastoma-associated,	hsa04110:Cell cycle,hsa05161:Hepatitis B,hsa05166:HTLV-I infection,hsa05169:Epstein-Barr virus infection,hsa05200:Pathways in cancer,hsa05203:Viral carcinogenesis,hsa05212:Pancreatic cancer,hsa05214:Glioma,hsa05215:Prostate cancer,hsa05218:Melanoma,hsa05219:Bladder cancer,hsa05220:Chronic myeloid leukemia,hsa05222:Small cell lung cancer,hsa05223:Non-small cell lung cancer,	109800~Bladder cancer, somatic,180200~Retinoblastoma,180200~Retinoblastoma, trilateral,182280~Small cell cancer of the lung, somatic,259500~Osteosarcoma, somatic,	SM00385:CYCLIN,SM01367:SM01367,SM01368:SM01368,SM01369:SM01369,	3D-structure,Acetylation,Cell cycle,Chromatin regulator,Complete proteome,Direct protein sequencing,Disease mutation,DNA-binding,Host-virus interaction,Methylation,Nucleus,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repressor,Transcription,Transcription regulation,Tumor suppressor,	chain:Retinoblastoma-associated protein,compositionally biased region:Poly-Ala,compositionally biased region:Poly-Pro,helix,modified residue,mutagenesis site,region of interest:Domain A,region of interest:Domain B,region of interest:Domain C; mediates interaction with E4F1,region of interest:Interaction with LIMD1,region of interest:Pocket; binds T and E1A,region of interest:Spacer,sequence conflict,sequence variant,short sequence motif:Nuclear localization signal,strand,turn,
4734	neural precursor cell expressed, developmentally down-regulated 4, E3 ubiquitin protein ligase(NEDD4)	Homo sapiens			GO:0002250~adaptive immune response,GO:0003151~outflow tract morphogenesis,GO:0003197~endocardial cushion development,GO:0006513~protein monoubiquitination,GO:0006622~protein targeting to lysosome,GO:0007041~lysosomal transport,GO:0007528~neuromuscular junction development,GO:0010766~negative regulation of sodium ion transport,GO:0010768~negative regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage,GO:0014068~positive regulation of phosphatidylinositol 3-kinase signaling,GO:0016241~regulation of macroautophagy,GO:0016567~protein ubiquitination,GO:0019089~transmission of virus,GO:0030948~negative regulation of vascular endothelial growth factor receptor signaling pathway,GO:0031175~neuron projection development,GO:0031623~receptor internalization,GO:0032801~receptor catabolic process,GO:0034644~cellular response to UV,GO:0034765~regulation of ion transmembrane transport,GO:0042110~T cell activation,GO:0042391~regulation of membrane potential,GO:0042787~protein ubiquitination involved in ubiquitin-dependent protein catabolic process,GO:0042921~glucocorticoid receptor signaling pathway,GO:0043162~ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway,GO:0044111~development involved in symbiotic interaction,GO:0045732~positive regulation of protein catabolic process,GO:0046824~positive regulation of nucleocytoplasmic transport,GO:0048514~blood vessel morphogenesis,GO:0048814~regulation of dendrite morphogenesis,GO:0050807~regulation of synapse organization,GO:0050847~progesterone receptor signaling pathway,GO:0051592~response to calcium ion,GO:0070534~protein K63-linked ubiquitination,GO:1901016~regulation of potassium ion transmembrane transporter activity,GO:2000650~negative regulation of sodium ion transmembrane transporter activity,	GO:0000151~ubiquitin ligase complex,GO:0000785~chromatin,GO:0005634~nucleus,GO:0005737~cytoplasm,GO:0005794~Golgi apparatus,GO:0005829~cytosol,GO:0005886~plasma membrane,GO:0005938~cell cortex,GO:0016327~apicolateral plasma membrane,GO:0048471~perinuclear region of cytoplasm,GO:0070062~extracellular exosome,	GO:0004842~ubiquitin-protein transferase activity,GO:0005515~protein binding,GO:0016874~ligase activity,GO:0019871~sodium channel inhibitor activity,GO:0019904~protein domain specific binding,GO:0031698~beta-2 adrenergic receptor binding,GO:0035255~ionotropic glutamate receptor binding,GO:0043130~ubiquitin binding,GO:0050815~phosphoserine binding,GO:0050816~phosphothreonine binding,GO:0061630~ubiquitin protein ligase activity,GO:0070063~RNA polymerase binding,GO:0070064~proline-rich region binding,	IPR000008:C2 calcium-dependent membrane targeting,IPR000569:HECT,IPR001202:WW domain,	hsa04120:Ubiquitin mediated proteolysis,hsa04144:Endocytosis,hsa05169:Epstein-Barr virus infection,		SM00119:HECTc,SM00239:C2,SM00456:WW,	3D-structure,Acetylation,Alternative splicing,Cell membrane,Complete proteome,Cytoplasm,Host-virus interaction,Membrane,Neurogenesis,Phosphoprotein,Polymorphism,Proteomics identification,Reference proteome,Repeat,Transferase,Ubl conjugation,Ubl conjugation pathway,	active site:Glycyl thioester intermediate,chain:E3 ubiquitin-protein ligase NEDD4,compositionally biased region:Ser-rich,domain:HECT,domain:WW 1,domain:WW 2,domain:WW 3,domain:WW 4,modified residue,sequence conflict,sequence variant,splice variant,strand,
